Home blood glucose monitor reduced Medicare reimbursement rates take effect Feb. 16.
This article was originally published in The Tan Sheet
Executive Summary
HOME BLOOD GLUCOSE MONITOR MEDICARE PAYMENT RATE REDUCTION will take effect Feb. 16, 1995 under a final rule published by the Health Care Financing Administration in the Jan. 17 Federal Register. The final rule sets the upper payment limit for new monitors furnished in the continental U.S. at $58.71, while the upper reimbursement level for new monitors furnished in Alaska, Hawaii, Puerto Rico or the Virgin Islands is set at $66.95.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning